Lysophosphatidic acid (LPA) is a lipid growth factor that exerts diverse biological effects through its cognate receptors (LPA 1 -LPA 6 ). LPA 1 , which is predominantly expressed in the brain, plays a pivotal role in brain development. However, the role of LPA 1 in neuronal migration has not yet been fully elucidated. Here, we delivered LPA 1 to mouse cerebral cortex using in utero electroporation. We demonstrated that neuronal migration in the cerebral cortex was not affected by the overexpression of LPA 1 . Moreover, these results can be applied to the identification of the localization of LPA 1 . The subcellular localization of LPA 1 was endogenously present in the perinuclear area, and overexpressed LPA 1 was located in the plasma membrane. Furthermore, LPA 1 in developing mouse cerebral cortex was mainly expressed in the ventricular zone and the cortical plate. In summary, the overexpression of LPA 1 did not affect neuronal migration, and the protein expression of LPA 1 was mainly located in the ventricular zone and cortical plate within the developing mouse cerebral cortex. These studies have provided information on the role of LPA 1 in brain development and on the technical advantages of in utero electroporation.
2010
; Ishii= et al., 2004; Moolenaar= et al., 2004; Yung= et al., 2014) . LPA signals through at least six specific membranebound G protein-coupled receptors (GPCRs) that are designated as LPA 1 /Vzg-1/Edg2, LPA 2 /Edg4, LPA 3 /Edg7, LPA 4 /p2y9/ GPR23, LPA 5 /GPR92, and LPA 6 /p2y5 (An=et al., 1998; Bandoh= et al., 1999; Hecht=et al., 1996; Kotarsky=et al., 2006; Lee=et al., 2006; Noguchi=et al., 2003; Pasternack=et al., 2008) . The lysophosphatidic acid receptor-1 (LPA 1 ), which was the first LPA receptor identified (Hecht et al., 1996) , was found to be involved in LPA signaling in the development of the central nervous system through studies involving the targeted deletion of LPA 1 (Contos= et al., 2000; Estivill-Torrus= et al., 2008; MatasRico=et al., 2008) . This receptor was shown to be expressed in the neurogenic region of the embryonic neocortical region, which is called the ventricular zone (VZ) (Hecht et al., 1996) .
Following the identification of LPA 1 , studies were directed towards understanding the role of LPA in the cortical development of mice. When LPA was not present in the VZ, neural progenitor cells underwent proliferation, differentiation, and cell death. In the presence of LPA, cell rounding and retraction fiber formation were observed in mouse cortical primary cells . In addition, LPA signaling regulated the formation of cerebral cortical folds that resemble gyri by affecting proliferation, differentiation, and cell survival during embryonic development (Kingsbury=et al., 2003) . The mouse embryonic cerebral cortex exhibited gene expression profiles of two LPA receptors (LPA 1 and LPA 2 ), suggesting important roles of LPA 1 and LPA 2 in cerebral cortical development (Kingsbury et al., 2003) . However, in many LPA studies, it has been difficult to localize the LPA receptor áå=îáîç.
Formerly, studies of the functional consequence and expression pattern of the LPA 1 receptor were performed with áå= ëáíì hybridization and reverse transcription polymerase chain reaction analysis (Cheng=et al., 2009; Hecht et al., 1996; Kim=et al., 2006; Spohr=et al., 2008; .
Since LPA1 receptors, like all G protein-couple receptors, cannot be easily visualized by an antibody, it is hard to discern the actual localization of the protein. Some papers have used LPA 1 antibodies to show the subcellular localization and expression of LPA 1 . These studies examined antibody specificity by blocking the signal with the overexpression of antisense LPA receptors or LPA receptor peptides (Gobeil= et al., 2003; Liszewska=et al., 2009; Moughal=et al., 2004; Waters=et al., 2006; Zheng= et al., 2001) . However, these studies were not conclusive.
In this study, we ectopically overexpressed LPA 1 in the developing mouse cerebral cortex using áå= ìíÉêç electroporation. LPA 1 overexpressed mice did not show obvious abnormalities in cerebral cortical development. In addition, we examined the subcellular localization and tissue distribution of LPA 1 in embryonic brain. The subcellular localization of LPA 1 in LPA 1 -overexpressing cells was mainly located in the plasma membrane and endogenously located in the perinuclear area. The tissue distribution of LPA 1 was mainly observed in the VZ and cortical plate (CP) of the embryonic cortex. Our studies revealed the subcellular localization of LPA 1 áå=îáîç and showed the technical advantage of antibody validation using áå= ìíÉêç electroporation.
MATERIALS AND METHODS

Animal
Pregnant mice of C57BL/6N strain were purchased from Orient Bio (Korea). Stage E0.5 was defined as noon on the day of the vaginal plug. Fetuses at E13.5, E15.5, and E17.5 were used for experiments.
Materials
All chemicals used were of analytical grade if not stated otherwise. Antibody to β-actin was obtained from Cell Signaling Technology (USA). Antibodies to LPA 1 , and green fluorescent protein (GFP) were purchased from Abcam (UK). Dulbecco's modified Eagle's Medium (DMEM), Opti-MEM I reduced-serum medium, 100 unit penicillin/100 μg streptomycin, fetal bovine serum (FBS), lipofectamine 2000, and DAPI were obtained from Invitrogen (USA).
Cell culture TR cells which is derived from neocortical neuroblast cells infected with the oncogenes Large T and îê~ë (Chun and Jaenisch, 1996) were maintained as monolayer cultures in Opti-MEM I reduced-serum medium supplemented with 2.5% heatinactivated fetal bovine serum, 20 mM glucose, 55 μM 2-mercaptoethanol, and 100 unit penicillin/ 100 μg streptomycin. B103 rat neuroblastoma cells were maintained in DMEM supplemented with 10% FBS. B103 cells were transiently transfected with pCAGIG or pCAGIG-LPA1 expression plasmid using the Lipofectamine 2000 reagent. After 24 h, the fluorescent images were acquired with an inverted microscope (IX70; Olympus).
Isolation of total protein and Western blot analysis TR cells were lysed in lysis buffer (50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 1 mM ethylene glycol tetraacetic acid (EGTA), 1 mM ethylenediaminetetraacetic acid (EDTA), 1% Triton X-100, 1 mM Na3VO4, 5 mM NaF, and protease inhibitor cocktail). After incubation on ice for 30 min, the lysates were centrifuged (15,000 × Ö, 15 min). Supernatants were collected and protein concentrations were determined by Bradford assay (Bio-Rad, USA). Equal amounts of protein were boiled and separated by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) transferred to polyvinylidene difluoride membranes (Millipore, USA), and blocked with 5% non-fat milk. Membranes were incubated in primary antibody overnight at 4°C. Membranes were then washed in TBST (10 mM Tris, 140 mM NaCl, 0.1% Tween 20, pH 7.6), incubated with appropriate secondary antibody, and washed again in TBST. Bands were visualized by chemiluminescence and exposed to X-ray film.
DNA constructs pCAGIG-LPA 1 expression vector design was based on the pCAGIG vector. The pCAGIG vector, which contains the IRES-EGFP cDNA under the control of the CMV enhancer and chick β-actin promoter, was a gift from Dr. C. Cepko (Matsuda and Cepko, 2004) . The full coding sequence for murine LPA 1 was obtained by reverse transcription PCR. Total RNA was prepared from the cerebellum of adult C57BL/6N mice using TRIzol reagent (Invitrogen). Total RNA (2 µg) was converted to cDNA using AMV reverse transcriptase (Promega, USA). The coding regions of mouse LPA 1 were PCR amplified from cDNA with the following 5′-bÅçRI-mLPA 1 and 3′-kçíI-mLPA 1 primer sets: 5′-CCGGAATTCATGGCAGCTGCCTCTACTT-3′, and 5′-GAGAGCGGCCGCTACACGGTCACCCCAGA-3′. The PCR product was subcloned into the pCAGIG vector at bÅçRI and kçíI sites. pCAGIG-LPA 1 construct was confirmed by automated sequencing.
In utero electroporation Timed-pregnant C57BL/6N females were anesthetized at stage embryonic day 13.5 (E13.5) with isoflurane (4% during induction, 2.5% during surgery), and the uterine horns were exposed by way of a laparotomy. The 1 μl of expression vector (4 μg/μl for pCAGIG and pCAGIG-LPA 1 constructs) in phosphate buffered saline (PBS) containing 0.05% fast green (Sigma-Aldrich, USA) was injected into the lateral ventricle of the embryo using a glass capillary with a length of 90 mm and a diameter of 1 mm (GD-1; Narishige, Japan). Electroporation was performed with a Tweezertrodes (diameter, 5 mm; BTX, USA) with 5 pulses of 45 V for 50 millisecond duration and 950 millisecond interval using a square-wave pulse generator (ECM 830; BTX). The uterine horns were then returned into the abdominal cavity, the wall and skin were sutured, and embryos were allowed to continue their normal development.
Immunohistochemistry
Electroporated embryonic brains were fixed with 4% paraformaldehyde (PFA) at 4°C for 2 h. Brains were cryoprotected in 30% sucrose /1× PBS at 4°C overnight and embedded in Tissue-Tek OCT (Sakura Finetek, USA). Cryosections (10 μm) were collected on MAS-coated glass slides (Matsunami Glass, Japan). Sections on glass slides were treated with heat in citrate buffer (10 mM, pH 6.0) at 95°C for 5 min. Samples were blocked in PBST containing 10% normal goat serum. The sections were incubated with primary antibodies against GFP (Abcam) (1:1000) and LPA 1 (Abcam) (1:1000) overnight at 4°C and then incubated in Alexa 488 and Alexa 568 conjugated secondary antibodies (Invitrogen) (1:1000) for one hour at room temperature. After washing, the specimens were mounted onto cover slips using Vectashield (Vector Laboratories, USA). The fluorescent images were acquired with a laser scanning confocal microscope (LSM510; Zeiss). For identify distribution of the GFP positive cells, images were converted gray values and normalized to background staining. Images were divide 10 equal bins spanning the cortical thickness and measured by ImageJ program (NIH).
In situ hybridization Cryosections (18 μm) were collected on MAS-coated glass slides (Matsunami Glass). mRNA for LPA 1 was detected by in situ hybridization using digoxygenin (DIG)-labeled antisense riboprobes. The sections were treated with proteinase K (1 μg/ml, 5-30 min, room temperature) and hybridized with 0.3 μg/ml riboprobe in a hybridization buffer (50% formamide, 20 mM Tris-HCl at pH 7.5, 600 mM NaCl, 1 mM EDTA, 10% dextran sulfate, 200 μg/ml yeast tRNA, 1× Denhardt's solution, 0.25% SDS) at 65°C overnight. The sections were washed three times with 1× SSC containing 50% formamide at 65°C, followed by maleic acid buffer (0.1 M, pH 7.5) containing 0.1% Tween 20 and 0.15 M NaCl. DIG-labeled probe was visualized by overnight incubation of the sections with anti-DIG antibody conjugated to alkaline phosphatase (1:2,000; Roche, USA) and NBT/BCIP reaction. The open reading frame of ié~êN antisense riboprobe was synthesized using a digoxygenin-labeled riboprobe with T7 RNA polymerase and a DIG-RNA labeling mix according to the manufacturer (Roche). The ié~êN riboprobe was a gift from Dr. Jerold Chun (The Scripps Research Institute).
RESULTS
Characterization of the spatiotemporal-specific LPA 1 -overexpressing mouse cerebral cortex To evaluate the importance of LPA 1 in neuronal migration in the developing cerebral cortex, we examined the overexpression of LPA 1 in the VZ by áå= ìíÉêç electroporation. First, we made a vector containing LPA 1 and tested it in B103 rat neuroblastoma cells. pGAGIG-LPA 1 encoding [LPA 1 /enhanced green fluorescent protein (EGFP)] -transfected cells displayed a flattened and more migratory morphology compared with pCAGIG (encoding EGFP)-transfected cells (data not shown). We injected a construct encoding EGFP or LPA 1 /EGFP into the lateral ventricle of E13.5 mouse embryos and transferred it into neuronal progenitor cells in the VZ by áå=ìíÉêç electroporation (Saito, 2006) . After allowing normal áå=îáîç embryonic development, immunohistochemistry for GFP was performed on coronal brain sections obtained from E15.5 mice. The expression of EGFP was detectable in many neurons of mice transfected with EGFP (Fig.  1A) or with LPA 1 and EGFP (Fig. 1B) . In EGFP-transfected control (Figs. 1A and 1C) , transfected cells were mainly located in the subventricular zone (SVZ) and intermediate zone (IZ), and some populations entered the cortical plate (CP). These neuronal migration patterns correlated with previously reported results (Langevin= et al., 2007) . With LPA 1 /EGFP-transfection 
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DAPI staining was used as a nuclear marker. Samples were analyzed by confocal microscopy in the following way: 10 z-stacks of each sample (1 μm apart) were taken and used to generate a two-dimensional image with Zeiss LSM software (Zeiss). Projections of these 2-D images are shown. Scale bar, 20 μm. (D, H) Higher magnification view of the square region in (C) and (G). Scale bar, 10 μm.
(Figs. 1B and 1D), LPA 1 did not affect neuronal migration or neuronal morphology in developing mouse cerebral cortex. Although LPA1 overexpression appeared to slightly delay neuronal migration in CP, it was not statistically significant. (Figs.  1C and 1D ). These results indicate that LPA 1 overexpression in cerebral cortex did not affect radial migration of neuronal progenitor cells. (Fig. 2) , demonstrated the specificity of the antibody used to detect LPA 1 . We next characterized the subcellular localization of LPA 1 using immunohistochemistry (Fig. 3) . At E15.5, 2 days after áå=ìíÉêç electroporation, we performed GFP and LPA 1 double immunostaining in EGFP-and LPA 1 /EGFP-transfected mice cerebral cortex. In EGFP-transfected controls, LPA 1 did not co-localize with the GFP signal (Figs. 3A-3C ). Interestingly, endogenous LPA 1 -positive signal, which was observed in the nuclear/perinuclear area of neuronal cells located in the VZ, formed a spot-like pattern (Fig. 3D) . In LPA 1 /EGFP-overexpressing cortices, LPA 1 expression co-localized with GFP (Figs. 3E-3G ). As shown in Fig. 3H , LPA 1 was mainly located in plasma membrane in LPA 1 -overexpressing neuronal cells. Additionally, endogenous LPA 1 -positive signals were the same as those seen in EGFP transfected controls (Fig. 3G) . Thus, these data show that the endogenous subcellular localization of LPA 1 , which exhibited a spot-like pattern, was located in the nuclear/perinuclear area, whereas the LPA 1 in LPA 1 -overexpressing cells was located in the plasma membrane.
LPA 1 is mainly expressed in ventricular zone of mouse embryonic cerebral cortex Due to the fact that our Western blotting and áå=ìíÉêç electroporation experiment revealed that the LPA 1 antibody was specific for detecting LPA 1 , we further identified the LPA 1 protein expression pattern in the cerebral cortex of (E13.5 to E17.5) embryonic mice (Figs. 5 and 6 ). First, we identified that the ié~êN transcript was mainly expressed in the VZ of cerebral cortex using in situ hybridization, as previously described (Hecht et al., 1996) (Fig. 4) . At E13.5, ié~êN antisense riboprobes revealed that a high level of expression of ié~êN was detected strictly in the VZ of cerebral cortex (Fig. 4A) . At E15.5, the level of ié~êN mRNA expression, which were exhibited in the VZ were slightly diminished (Fig. 4C) . At E17.5, ié~êN mRNA in VZ was barely detectable (Fig. 4E) . Immunohistochemical analysis confirmed that LPA 1 was located in the cerebral cortex at E13.5 (Fig. 5) . In particular, LPA 1 levels were highly enriched within the VZ (Figs.  5A and 5B) and the lens (Figs. 5A and 5C ). To examine the expression pattern of LPA 1 during cortical development, we performed immunostaining on sagittal brain sections obtained from E13.5 to E17.5 mice (Fig. 6 ). At E13.5, immunostaining of LPA 1 revealed that a high level of LPA 1 was detected in the VZ of cerebral cortex. At E15.5, LPA 1 levels were high in the VZ and the CP. At E17.5, the levels of LPA 1 were highly enriched within the VZ and upper layer of the CP. Taken together, these data demonstrate that LPA 1 was expressed in the VZ and upper layer of the CP in the cerebral cortex of developing mice.
DISCUSSION
The aim of the present study was to characterize functional consequence of LPA 1 in the developing cerebral cortex. Our results provide an additional understanding of the role of LPA 1 in the developing cerebral cortex and of the technical application of áå=ìíÉêç electroporation for the validation of antibodies. We used áå=ìíÉêç electroporation to uncover the role of LPA 1 in neuronal migration from the VZ to the CP. The overexpression of LPA 1 in newly postmitotic cells of the VZ did not show any obvious abnormality in the neuronal migration to the CP (Fig. 1) . LPA 1 , which is endogenously expressed in the VZ (Hecht et al., 1996) , has an important role in the maintenance of neuroprogenitor pools in the VZ (Kingsbury et al., 2003) . The LPA receptor-mediated signaling is regulated by their ligand, LPA. Thus, the levels of LPA may be low in the SVZ and IZ. Thus, the ectopic expression of LPA 1 did not change neuronal migration in the cerebral cortex.
An examination of the subcellular localization of LPA 1 was performed by immunohistochemistry (Fig. 3) . In LPA 1 -overexpressing cerebral cortical cells, LPA 1 , which colocalized with EGFP fluorescence, was predominantly expressed in the plasma membrane (Fig. 3H) . These results were similar to those previously reported in a study of LPA 1 overexpression in a cellbased assay (Avendano-Vazquez= et al., 2005; Murph= et al., 2003; Urs=et al., 2005) .
In EGFP expressing control cerebral cortex, LPA 1 and EGFP signal did not colocalize, and the endogenous LPA 1 -positive signal was located in the perinuclear area and looked like an LPA 1 oligomer (Fig. 3D) . G protein-coupled receptor (GPCR) oligomerization has recently been widely accepted, and the number of documented oligomeric GPCR combinations is extensive (Filizola, 2010; Gurevich and Gurevich, 2008; Maggio=et al., 2005; Milligan, 2009; Vidi=et al., 2011) . Active GPCRs are specifically phosphorylated by G-protein-coupled receptor kinases (GRKs), initiating arrestin recruitment. Receptor/arrestin complexes than recruit two components of the internalization machinery (clathrin and AP-2) and a variety of other proteins, initiating the second round of signaling (DeWire= et al., 2007; Moore=et al., 2007) . Thus, GPCR oligomerization may be regulated by arrestin-mediated signaling (Gurevich and Gurevich, 2008) . Arrestin is important in the LPA induced signaling cascade, and LPA 1 internalization is regulated by arrestin mediated pathway (DeWire et al., 2007; Gesty-Palmer=et al., 2005; Sun and Lin, 2008; Sun and Yang, 2010; Urs et al., 2005; . Another report showed that LPA 1 can dimerize (Zaslavsky=et al., 2006) . Our observation of ventricular zone cells that were immunopositive to LPA1 antibody with puncta morphology is intriguing. We speculate that these intracellular puncta might have been formed after LPA1 are bound to ligands (i.e., lysophosphatitic acids), followed by internalization of this receptor-ligand complex into the cells. Taken together, these results suggest that activated LPA 1 is internalized and oligomerized by arrestin scaffolding.
In a previous áå=ëáíì hybridization study, the ié~êN expression pattern was mainly located in the VZ of the cerebral cortex of developing mouse (Hecht et al., 1996) . We performed áå= ëáíì hybridization of ié~êN in the cerebral cortex and found the same expression pattern of the ié~êN transcript (Fig. 4) . In Figs. 5 and 6, the protein expression pattern of LPA 1 is mainly located in the VZ and the CP. During cortical development, postmitotic neurons migrate toward the CP from the VZ and pass the IZ. Within the CP, radially migrating cells become arranged in an inside-out pattern in which the earlier generated neurons occupy deeper layers, and those generated later become located in more superficial layers (Aboitiz= et al., 2001 ). These previous reports indicated that the transcripts of ié~êN are located in the VZ, and LPA 1 -expressing cells migrate toward the CP from VZ. Thus, LPA 1 protein is located in the VZ and CP of the cerebral cortex of mice. This observation requires further studies with functional consequence of LPA 1 expressed in VZ and CP.
Nowadays, áå=ìíÉêç electroporation is a widely used and well established experimental method. It has a several advantage like region-specific, cell type-specific, inducible, and multiple gene targeting. Moreover, it can apply to region dependent behaviors and functional outcome test (De Vry= et al., 2010; Taniguchi=et al., 2012) . Besides the above advantages of the áå= ìíÉêç electroporation, it can easily introduce specific genes áå= îáîç condition. Despite many targeted GPCR antibody is available but can't easily find validated antibody, for this reason áå= ìíÉêç electroporation is a powerful tools for quick and easily find good antibody from hardly discern GPCR.
In summary, our results provide information on the subcellular localization and tissue distribution of LPA 1 and the technical advantages of the use of áå=ìíÉêç electroporation for the validation of antibodies.
